The largest database of trusted experimental protocols

6 protocols using recombinant mouse icam 1 fc

1

ICAM-1-Fc-F(ab')₂ Complexes Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate ICAM-1-Fc-F(ab’)2 complexes (scICAM-1) APC- or PE- labelled anti-human Fcγ specific IgG F(ab’)2 fragments (Jackson ImmunoResearch) and recombinant mouse ICAM-1 Fc (R&D Systems) were incubated at 4°C for 30 min in PBS as described previously30 (link).
Primary CD4+ T cells were incubated for 30 min at 4°C with 1 μg/ml of anti-CD3ε (2C11). The cells were then activated by crosslinking with anti-Armenian Hamster IgG at 37°C in presence of scICAM-1. For the control experiments the cells were activated with PMA (50 ng/ml) or Mg2+/EGTA (10 mM / 1 mM) or CCL19 (250 ng/ml). After the indicated time the reaction was stopped by fixation with 4% PFA for 5 min. The samples were then washed in PBS+10% FCS, stained with PE- or APC-labelled anti-CD4 and analysed on a FACS-Calibur.
For LFA-1 clustering experiments, T cells were incubated with anti-CD3ε for 30 min on ice. Cells were then washed and cross-linked with anti-Armenian Hamster IgG for 30 min at 37°C. Cells were fixed with 4% PFA, washed and block with 10% FCS-PBS for 30 min. Cells were then stained for anti-CD11a and imaged on a Olympus FV1000 microscope fitted with a Olympus Plan super Apochromat 60×/1.4 NA oil objective.
+ Open protocol
+ Expand
2

T-cell Adhesion Molecule Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For assessment of T‐cell binding to recombinant cell adhesion molecules, 18 field teflon slides (Thermo Fisher Scientific Inc., Waltham, USA) were precoated with protein A (BioVision, Axxora Europe, Lausen, Switzerland) for 1 h at 37°C. After washing steps with binding assay medium (BAM: DMEM with 25 mM HEPES and 5% FCS) and blocking with 1.5% BSA, purified recombinant mouse ICAM‐1 Fc, (R&D Systems, Abingdon, UK), recombinant VCAM‐1 Fc (R&D Systems) and as control DNER Fc (R&D Systems) were overlaid in a concentration of 10 μg/mL and incubated for 2 h at 37°C. After washing with BAM and blocking with 1.5% BSA, T cells were added in BAM (5 × 106 cells/mL) and incubated on a rotating platform for 30 min at 4°C. After washing in slides were fixed in 2.5% glutaraldehyde for 2 h at room temperature. Cells bound per FOV were counted using an ocular with a 10 ×10 field counting grid.
+ Open protocol
+ Expand
3

Multiparametric Phenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were from BioLegend: CD3 (17A2, 2C11), CD4 (GK1.5), CD8 (53–6.7), CD44 (1M7), CD62L (MEL-14), B220 (RA3-6B2), CD29 (HMβ1-1), CD18 (M18/2), β7 (FIB504), Foxp3 (MF-14), CD28 (37.51), IL-10 (JES5-16E3), and TGF-β1 (TW7-16B4). Secondary Alexa Fluor–labeled antibodies were from Jackson ImmunoResearch. Foxp3 transcription factor fixation/permeabilization kit was purchased from eBioscience. CFSE and eFluor 670 were purchased from Invitrogen and BioLegend respectively. PMA and piroxicam were from Sigma. Ionomycin, brefeldin A, and monensin were from BioLegend. MojoSort mouse CD3 T cell isolation kit and mouse CD4 T cell isolation kit were from BioLegend. Liberase TL (Research Grade) and DNase I were from Roche. Recombinant mouse ICAM-1-Fc and VCAM-1-Fc were from R&D Systems. Recombinant mouse MAdCAM-1-Fc was purified by ProteinA beads as previously described (Sun et al., 2011 (link)).
+ Open protocol
+ Expand
4

Soluble ICAM-1 Binding Assay for T Cell Integrins

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze β2‐integrin affinity on OT1 and OT2 T cells, we performed a soluble ICAM‐1‐binding assay as previously described 63. As a positive control T cells were preincubated with 2 mM MnCl2 and as a negative control with a cocktail of function blocking anti‐β2‐integrin antibodies (anti‐LFA‐1 (M17/4; 20 μg/mL) and anti‐Mac1 (M1/70; 50 μg/mL) for 10 min at RT. Recombinant mouse ICAM‐1 Fc, (R&D Systems, Abingdon, UK, final concentration 20 μg/mL) was preincubated with PE‐conjugated donkey F(ab')₂ anti‐human IgG (H + L) (Jackson ImmunoResearch) for 10 min at 20°C prior to incubation for 3 or 5 min at 37°C with the CD4+ and CD8+ T cells. Following fixation in 7.4% formaldehyde soluble ICAM‐1 binding to the T cells was assessed by flow cytometry.
+ Open protocol
+ Expand
5

T cell Activation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
anti-CD3 (2C11) and anti-CD28 (PV1) were from BioXCell. Anti-CrkL (SC-319) was from Santa Cruz. anti-CD3-FITC was from E-biosciences. Anti-Crk (#610036), Anti-CD8-FITC, anti-CD3, anti-CD45.1, anti-H-2Kb-Pacific Blue, anti-CD45.2-APC and LIVE/DEAD Fixable Aqua Dead Cell Stain Kit were from BD Bioscience. Secondary antibodies conjugated to appropriate fluorophores and AlexaFluor 488-conjugated phalloidin were obtained from Molecular Probes. Luciferin was purchased from Perkin Elmer and Gold Bio. Recombinant mouse ICAM-1-Fc was from R&D Systems.
+ Open protocol
+ Expand
6

Immune Cell Activation Pathway Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD3 clone 2C-11, anti-CD28 clone PV1, and LFA-1 blocking anti-CD11a clone M17/4 were obtained from BioXCell. Anti-pTyr clone PY-20 and anti-p85 (ABS234) was from Upsate (Millipore). Anti-HEF1 (CasL) clone 2G9 and anti-Pyk2 clone YE353 were obtained from Abcam. Anti-Rac1 (610650) and anti-AKT (559028) were from BD. Anti-pAKT (4051), anti-pERK (9101), and anti-c-Cbl (2747) were from Cell Signaling. Anti-Cdc42 (SC-87), anti-CrkL (SC-319), and anti-Cbl-b (SC-8006) were from Santa Cruz. Secondary antibodies conjugated to appropriate fluorophores were obtained from Molecular Probes and Jackson Immunoresearch. AlexaFluor-conjugated phalloidin was purchased from Molecular Probes. Recombinant mouse ICAM-1-Fc, SDF-1α, and P-selectin were purchased from R&D Systems. The ROCK inhibitor Y-27632, the pan PI3K inhibitor LY-294002, and the PI3Kδ inhibitor IC87114 were obtained from CalBiochem. The myosin inhibitor (s)-nitro-blebbistatin was purchased from Cayman Chemicals. The actin destabilizing drug latrunculin B, the Src inhibitor PP2, the Abl kinase inhibitor STI-571, and the PI3Kγ inhibitor CZC24832 were purchased from Sigma.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!